Stockscreener 앱 받기
18.75
1.00%
-0.19
시간 외 거래:
18.70
-0.05
-0.27%
전일 마감가:
$18.94
열려 있는:
$18.94
하루 거래량:
251.65K
Relative Volume:
0.92
시가총액:
$481.66M
수익:
-
순이익/손실:
$11.77M
주가수익비율:
32.41
EPS:
0.5785
순현금흐름:
$-19.23M
1주 성능:
+0.81%
1개월 성능:
+10.68%
6개월 성능:
+6.90%
1년 성능:
+13.77%
1일 변동 폭
$18.63
$19.59
1주일 범위
$17.84
$19.59
52주 변동 폭
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
명칭
Tourmaline Bio Inc
전화
646-481-9832
주소
27 WEST 24TH STREET, NEW YORK
TRML을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
18.75 | 484.48M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-15 | 개시 | Jefferies | Buy |
| 2023-12-04 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2023-10-31 | 개시 | Guggenheim | Buy |
| 2023-10-25 | 개시 | Piper Sandler | Overweight |
| 2022-10-20 | 개시 | H.C. Wainwright | Buy |
| 2022-07-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
모두보기
Tourmaline Bio Inc 주식(TRML)의 최신 뉴스
Why Tourmaline Bio Inc. stock is on top investor watchlistsFree Investment Timing Strategies - jammulinksnews.com
What analysts say about Tourmaline Bio Inc. stockDouble-digit growth - Autocar Professional
Tourmaline Bio Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional
Is Tourmaline Bio Inc. a good long term investmentExceptional gains - Autocar Professional
What drives Tourmaline Bio Inc. stock priceMarket-leading profit generation - jammulinksnews.com
What drives SuRo Capital Corp. stock priceRapid wealth multiplication - jammulinksnews.com
High Growth Stocks in India s Emerging Markets Trusted Market PredictionsRapid market gains - Autocar Professional
What drives NMTC stock priceRemarkable growth - jammulinksnews.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of “Buy” from Brokerages - Defense World
What analysts say about TACOU stockPowerful profit generation - Jammu Links News
Is Nuburu Inc. a good long term investmentFree Investment Case Studies - Jammu Links News
What drives Warrior Met Coal Inc. stock priceFree Daily Trading Room Entry - Jammu Links News
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
should you buy bull(mumu the bull erc)Free Top Growth Stock Recommendations - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
How Tourmaline Bio Inc. stock performs during market volatilityFree Discussion Group - Newser
What makes Tourmaline Bio Inc. stock price move sharplyCarefully Curated High Return Stocks - Newser
What makes Universe Pharmaceuticals INC stock price move sharplyInsider Level Guidance - Newser
How Cross Country Healthcare Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
How Orange County Bancorp Inc. stock performs during market volatilityDouble Profit With Half Risk - Newser
What makes Synopsys Inc. stock price move sharplyPro Trader Stock Focus - Newser
Why XRLX stock attracts strong analyst attentionFree Stock Trading Signals - Newser
How KRON stock performs during market volatilityVerified Return Tips - Newser
Tourmaline Bio Inc (TRML) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.32%
1.57%
자본화:
|
볼륨(24시간):